Work

OP0251 Attainment of low disease activity and remission in systemic lupus erythematosus patients with high disease activity in the atacicept phase iib address ii study and its long-term extension

Year: 2018

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2018-eular.2618

Authors: E. Morand, J.T. Merrill, D.A. Isenberg, A.H. Kao, C. Vazquez–Mateo, S. Wax, P. Chang, K. Pudota, C. Aranow, D. Wallace

Institutions: Monash University, Oklahoma Medical Research Foundation, University College London, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), Feinstein Institute for Medical Research, Cedars-Sinai Medical Center, University of California, Los Angeles

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2884350858

Cites:

Cited by: 5

Related to: 10